TY  - JOUR
A1  - Galbete, Cecilia
A1  - Kröger, Janine
A1  - Jannasch, Franziska
A1  - Iqbal, Khalid
A1  - Schwingshackl, Lukas
A1  - Schwedhelm, Carolina
A1  - Weikert, Cornelia
A1  - Boeing, Heiner
A1  - Schulze, Matthias Bernd
T1  - Nordic diet, Mediterranean diet, and the risk of chronic diseases
BT  - the EPIC-Potsdam study
JF  - BMC Medicine
N2  - Background: The Mediterranean Diet (MedDiet) has been acknowledged as a healthy diet. However, its relation with risk of major chronic diseases in non-Mediterranean countries is inconclusive. The Nordic diet is proposed as an alternative across Northern Europe, although its associations with the risk of chronic diseases remain controversial. We aimed to investigate the association between the Nordic diet and the MedDiet with the risk of chronic disease (type 2 diabetes (T2D), myocardial infarction (MI), stroke, and cancer) in the EPIC-Potsdam cohort. Methods: The EPIC-Potsdam cohort recruited 27,548 participants between 1994 and 1998. After exclusion of prevalent cases, we evaluated baseline adherence to a score reflecting the Nordic diet and two MedDiet scores (tMDS, reflecting the traditional MedDiet score, and the MedPyr score, reflecting the MedDiet Pyramid). Cox regression models were applied to examine the association between the diet scores and the incidence of major chronic diseases. Results: During a follow-up of 10.6 years, 1376 cases of T2D, 312 of MI, 321 of stroke, and 1618 of cancer were identified. The Nordic diet showed a statistically non-significant inverse association with incidence of MI in the overall population and of stroke in men. Adherence to the MedDiet was associated with lower incidence of T2D (HR per 1 SD 0.93, 95% CI 0.88-0.98 for the tMDS score and 0.92, 0.87-0.97 for the MedPyr score). In women, the MedPyr score was also inversely associated with MI. No association was observed for any of the scores with cancer. Conclusions: In the EPIC-Potsdam cohort, the Nordic diet showed a possible beneficial effect on MI in the overall population and for stroke in men, while both scores reflecting the MedDiet conferred lower risk of T2D in the overall population and of MI in women.
KW  - Mediterranean diet
KW  - Nordic diet
KW  - regional diets
KW  - chronic diseases
KW  - diabetes
KW  - myocardial infarction
KW  - stroke
KW  - cancer
KW  - EPIC-Potsdam study
KW  - longitudinal analysis
Y1  - 2018
U6  - https://doi.org/10.1186/s12916-018-1082-y
SN  - 1741-7015
VL  - 16
PB  - BMC
CY  - London
ER  - 
TY  - JOUR
A1  - Ladwig, Simon
A1  - Zhou, Zien
A1  - Xu, Ying
A1  - Wang, Xia
A1  - Chow, Clara K.
A1  - Werheid, Katja
A1  - Hackett, Maree L.
T1  - Comparison of treatment rates of depression after stroke versus myocardial infarction
BT  - a systematic review and meta-analysis of observational data
JF  - Psychosomatic medicine
N2  - Objective Depression after stroke and myocardial infarction (MI) is common but often assumed to be undertreated without reliable evidence being available. Thus, we aimed to determine treatment rates and investigate the application of guidelines in these conditions. Methods Databases MEDLINE, EMBASE, PsycInfo, Web of Science, CINAHL, and Scopus were systematically searched without language restriction from inception to June 30, 2017. Prospective observational studies with consecutive recruitment reporting any antidepressant treatment in adults with depression after stroke or MI were included. Random-effects models were used to calculate pooled estimates of treatment rates. Results Fifty-five studies reported 32 stroke cohorts (n = 8938; pooled frequency of depression = 34%, 95% confidence interval [CI] = 29%-38%) and 17 MI cohorts (n = 10,767; pooled frequency of depression = 24%, 95% CI = 20%-28%). In 29 stroke cohorts, 24% (95% CI = 20%-27%) of 2280 depressed people used antidepressant medication. In 15 MI cohorts, 14% (95% CI = 8%-19%) of 2381 depressed people used antidepressant medication indicating a lower treatment rate than in stroke. Two studies reported use of psychosocial interventions, indicating that less than 10% of participants were treated. Conclusions Despite the high frequency of depression after stroke and MI and the existence of efficacious treatment strategies, people often remain untreated. Innovative strategies are needed to increase the use of effective antidepressive interventions in patients with cardiovascular disease.
KW  - depression
KW  - myocardial infarction
KW  - pharmacoepidemiology
KW  - stroke
KW  - treatment
Y1  - 2018
U6  - https://doi.org/10.1097/PSY.0000000000000632
SN  - 0033-3174
SN  - 1534-7796
VL  - 80
IS  - 8
SP  - 754
EP  - 763
PB  - Lippincott Williams & Wilkins
CY  - Philadelphia
ER  -